US5688819A
(en)
*
|
1992-09-21 |
1997-11-18 |
Allergan |
Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
US5972991A
(en)
*
|
1992-09-21 |
1999-10-26 |
Allergan |
Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
US6184250B1
(en)
*
|
1993-08-03 |
2001-02-06 |
Alcon Laboratories, Inc. |
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
|
US5510383A
(en)
|
1993-08-03 |
1996-04-23 |
Alcon Laboratories, Inc. |
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
|
WO1997023225A1
(fr)
*
|
1995-12-22 |
1997-07-03 |
Alcon Laboratories, Inc. |
Combinaisons de prostaglandines de type dp et fp destinees a abaisser la pression intraoculaire
|
EP0930296B2
(fr)
*
|
1996-09-17 |
2005-11-02 |
Asahi Glass Company Ltd. |
Derives de prostaglandine fluores et medicaments
|
EP0948333A1
(fr)
*
|
1996-11-01 |
1999-10-13 |
Alcon Laboratories, Inc. |
Utilisation d'une combinaison d'inhibiteurs d'anhydrase carbonique et de prostaglandines dans le traitement du glaucome
|
ES2159889T3
(es)
|
1996-11-12 |
2001-10-16 |
Alcon Lab Inc |
15-fluoro prostaglandinas utilizadas como hipotensores oculares.
|
WO1998020880A2
(fr)
*
|
1996-11-12 |
1998-05-22 |
Alcon Laboratories, Inc. |
11-halo prostaglandines destinees au traitement du glaucome ou de l'hypertension oculaire
|
US6680339B2
(en)
|
1996-11-12 |
2004-01-20 |
Alcon Manufacturing, Ltd. |
15-fluoro prostaglandins as ocular hypotensives
|
JP3480549B2
(ja)
*
|
1996-12-26 |
2003-12-22 |
参天製薬株式会社 |
ジフルオロプロスタグランジン誘導体およびその用途
|
WO1999012898A1
(fr)
*
|
1997-09-09 |
1999-03-18 |
The Procter & Gamble Company |
Prostaglandines tetrahydro a substitution aromatique c16-c20, utiles comme agonistes de prostaglandine f
|
JP2001515882A
(ja)
*
|
1997-09-09 |
2001-09-25 |
ザ プロクター アンド ギャンブル カンパニー |
Fpアゴニストとして有用な、芳香族のあるc16〜c20が置換されたテトラヒドロプロスタグランジン類
|
US6066671A
(en)
|
1997-12-19 |
2000-05-23 |
Alcon Laboratories, Inc. |
Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
|
US6646001B2
(en)
|
1997-12-19 |
2003-11-11 |
Alcon Manufacturing, Ltd. |
Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
|
US6225348B1
(en)
|
1998-08-20 |
2001-05-01 |
Alfred W. Paulsen |
Method of treating macular degeneration with a prostaglandin derivative
|
KR20010108316A
(ko)
|
1999-03-05 |
2001-12-07 |
데이비드 엠 모이어 |
C16 불포화된 fp-선택적 프로스타글란딘 유사체
|
US6294679B1
(en)
*
|
1999-04-12 |
2001-09-25 |
Chirotech Technology Limited |
Intermediate for the synthesis of prostaglandins
|
US6214611B1
(en)
|
1999-04-12 |
2001-04-10 |
Chirotech Technology Limited |
Process for the preparation of prostaglandin precursors
|
GB9908326D0
(en)
*
|
1999-04-12 |
1999-06-09 |
Chirotech Technology Ltd |
Novel process intermediate for the synthesis of prostaglandins
|
US6894175B1
(en)
*
|
1999-08-04 |
2005-05-17 |
The Procter & Gamble Company |
2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
|
TWI290470B
(en)
|
1999-12-01 |
2007-12-01 |
Sankyo Co |
The composition for treating glaucoma
|
WO2001055102A1
(fr)
*
|
2000-01-28 |
2001-08-02 |
Asahi Glass Company, Limited |
Nouveau derive difluoroprostaglandine
|
EP1261598A1
(fr)
*
|
2000-02-01 |
2002-12-04 |
Cayman Chemical Company, Inc. |
1,15-lactones internes de fluprostenol et analogues de prostaglandine f2alpha apparentes, et leur utilisation dans le traitement du glaucome et de l'hypertension intraoculaire
|
US6806285B1
(en)
|
2000-03-17 |
2004-10-19 |
Alcon, Inc. |
5-Hydroxyl indole derivatives for treating glaucoma
|
US7005443B1
(en)
|
2000-03-17 |
2006-02-28 |
Alcon, Inc. |
5-Hydroxy indazole derivatives for treating glaucoma
|
US6956036B1
(en)
|
2000-03-17 |
2005-10-18 |
Alcon, Inc. |
6-hydroxy-indazole derivatives for treating glaucoma
|
US7012090B1
(en)
|
2000-03-17 |
2006-03-14 |
Alcon, Inc. |
Pyranoindoles for treating glaucoma
|
US20030119846A1
(en)
*
|
2000-03-17 |
2003-06-26 |
Collier Jr Robert J. |
Compounds with 5-ht activity useful for controlling visual field loss
|
US6660870B1
(en)
|
2000-03-17 |
2003-12-09 |
Alcon, Inc. |
2-acylaminobenzimidazole derivatives for treating glaucoma
|
US6927233B1
(en)
|
2000-03-17 |
2005-08-09 |
Alcon, Inc. |
5ht2 agonists for controlling IOP and treating glaucoma
|
US20020146439A1
(en)
*
|
2000-03-31 |
2002-10-10 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
|
US20020172693A1
(en)
*
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
US20020037914A1
(en)
*
|
2000-03-31 |
2002-03-28 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
|
US20020013294A1
(en)
*
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
WO2004098807A1
(fr)
*
|
2000-11-21 |
2004-11-18 |
Barsplice Products, Inc. |
Procede de fabrication de coupleurs en acier permettant d'assembler des barres d'armature du beton
|
SE0100158D0
(sv)
*
|
2001-01-19 |
2001-01-19 |
Synphora Ab |
Novel method and composition for local treatment of Meniere´s disease and tinnitus
|
US20050171054A1
(en)
*
|
2001-01-19 |
2005-08-04 |
Helge Rask-Andersen |
Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss
|
US20040198829A1
(en)
*
|
2001-04-23 |
2004-10-07 |
Sponsel William Eric |
Prostanoids augment ocular drug penetration
|
US20030212107A1
(en)
*
|
2001-05-10 |
2003-11-13 |
Kapin Michael A. |
R-reliprodil for treating glaucoma
|
GB0112699D0
(en)
*
|
2001-05-24 |
2001-07-18 |
Resolution Chemicals Ltd |
Process for the preparation of prostglandins and analogues thereof
|
JP2004532887A
(ja)
*
|
2001-06-01 |
2004-10-28 |
アルコン,インコーポレイテッド |
新規な融合インダゾールおよびインドールおよび緑内障治療へのこれらの使用
|
CA2447479A1
(fr)
*
|
2001-06-01 |
2002-12-12 |
Alcon, Inc. |
Nouveaux analogues d'arylaminopropane et leur utilisation dans le traitement du glaucome
|
DE60209486T2
(de)
*
|
2001-06-01 |
2006-08-03 |
Alcon Inc. |
Pyranoindazole und ihre verwendung in der glaukombehandlung
|
US6884816B2
(en)
*
|
2001-08-31 |
2005-04-26 |
Alcon, Inc. |
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
|
US20040254230A1
(en)
*
|
2001-12-03 |
2004-12-16 |
Ogidigben Miller J. |
Method for treating ocular hypertension
|
US8758733B2
(en)
|
2002-02-04 |
2014-06-24 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
US9216183B2
(en)
|
2002-02-04 |
2015-12-22 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
US7351404B2
(en)
*
|
2002-02-04 |
2008-04-01 |
Allergan, Inc. |
Method of enhancing hair growth
|
US20040110776A1
(en)
*
|
2002-02-22 |
2004-06-10 |
Iok-Hou Pang |
Use of propentofylline to control intraocular pressure
|
DE60326226D1
(de)
*
|
2002-03-21 |
2009-04-02 |
Cayman Chemical Co |
Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom
|
CA2488001C
(fr)
|
2002-06-06 |
2011-03-22 |
Merck Frosst Canada & Co. |
Derives de pyrrolid-2-one 1,5 disubstitues utilises comme agonistes de recepteur ep4 pour traiter des maladies oculaires telles que le glaucome
|
JP2005534653A
(ja)
*
|
2002-06-06 |
2005-11-17 |
メルク フロスト カナダ アンド カンパニー |
眼及び骨疾患の治療に於いてep4受容体作動薬として使用するための1,5−二置換イミダゾリジン−2−オン誘導体
|
US6864282B2
(en)
*
|
2002-08-05 |
2005-03-08 |
Allergan, Inc. |
9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
|
JP2006504679A
(ja)
*
|
2002-08-28 |
2006-02-09 |
メルク フロスト カナダ アンド カンパニー |
緑内障の治療においてep4受容体作動薬として使用するためのオキサゾリジン−2−オンおよびチアゾリジン−2−オン誘導体
|
ES2382733T3
(es)
*
|
2002-08-29 |
2012-06-13 |
Santen Pharmaceutical Co., Ltd. |
Remedio para el glaucoma que comprende un inhibidor de la Rho quinasa y prostaglandinas
|
CN1678302A
(zh)
*
|
2002-08-30 |
2005-10-05 |
爱尔康公司 |
取代的5-苯并二氢吡喃-5-基-乙胺化合物及其在治疗青光眼中的用途
|
JP2006505572A
(ja)
*
|
2002-10-25 |
2006-02-16 |
メルク フロスト カナダ アンド カンパニー |
Ep4受容体アゴニストとしての2−ピロリドン
|
CA2505127A1
(fr)
*
|
2002-11-08 |
2004-05-27 |
James B. Doherty |
Compositions ophtalmiques pour traiter l'hypertension oculaire
|
US7196082B2
(en)
*
|
2002-11-08 |
2007-03-27 |
Merck & Co. Inc. |
Ophthalmic compositions for treating ocular hypertension
|
US20070088045A1
(en)
*
|
2002-11-12 |
2007-04-19 |
Hellberg Peggy E |
Histone deacetylase inhibitors for treating degenerative diseases of the eye
|
US20080004311A1
(en)
*
|
2002-11-12 |
2008-01-03 |
Alcon, Inc. |
Histone deacetylase inhibitors for treating degenerative diseases of the eye
|
ES2444841T3
(es)
|
2002-11-18 |
2014-02-27 |
Santen Pharmaceutical Co., Ltd. |
Remedio para el glaucoma que comprende inhibidor de Rho cinasa y beta-bloqueante
|
US7053085B2
(en)
*
|
2003-03-26 |
2006-05-30 |
Merck & Co. Inc. |
EP4 receptor agonist, compositions and methods thereof
|
MXPA05005937A
(es)
*
|
2002-12-06 |
2005-08-18 |
Alcon Inc |
Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares.
|
CA2506204A1
(fr)
*
|
2002-12-13 |
2004-07-01 |
Alcon, Inc. |
Nouveaux analogues de benzopyranne et leur utilisation pour le traitement du glaucome
|
US20040225014A1
(en)
*
|
2003-02-14 |
2004-11-11 |
Sucampo Ag |
Method for treating ocular hypertension and glaucoma
|
EP1646614A4
(fr)
*
|
2003-07-01 |
2008-09-10 |
Merck & Co Inc |
Compositions ophtalmiques destinees au traitement d'hypertension oculaire
|
US20050119262A1
(en)
*
|
2003-08-21 |
2005-06-02 |
Pharmacia Corporation |
Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
|
CN1845914A
(zh)
*
|
2003-09-02 |
2006-10-11 |
默克公司 |
用于治疗眼压过高的眼用组合物
|
AU2004272546B2
(en)
*
|
2003-09-04 |
2007-10-18 |
Merck Sharp & Dohme Corp. |
Ophthalmic compositions for treating ocular hypertension
|
US7494983B2
(en)
*
|
2003-09-04 |
2009-02-24 |
Merck & Co. Inc. |
Ophthalmic compositions for treating ocular hypertension
|
US20070093507A1
(en)
*
|
2003-09-05 |
2007-04-26 |
Lambrou George N |
Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives
|
PL1681059T3
(pl)
|
2003-11-07 |
2010-01-29 |
Senju Pharma Co |
Kompozycja farmaceutyczna zawierająca prostaglandynę
|
US7476687B2
(en)
*
|
2003-11-26 |
2009-01-13 |
Alcon, Inc. |
Substituted furo[2,3-g]indazoles for the treatment of glaucoma
|
US6989445B2
(en)
*
|
2003-12-15 |
2006-01-24 |
Alcon, Inc. |
Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
US7129257B1
(en)
*
|
2003-12-15 |
2006-10-31 |
Alcon, Inc. |
Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
|
GB0329620D0
(en)
*
|
2003-12-22 |
2004-01-28 |
Pharmagene Lab Ltd |
EP2 receptor agonists
|
WO2005079809A1
(fr)
*
|
2004-02-19 |
2005-09-01 |
Santen Pharmaceutical Co., Ltd. |
Gouttes pour les yeux transparentes au latanoprost
|
JP2005263792A
(ja)
*
|
2004-02-19 |
2005-09-29 |
Santen Pharmaceut Co Ltd |
澄明なラタノプロスト点眼液
|
PL1740164T3
(pl)
*
|
2004-04-26 |
2009-01-30 |
Alcon Inc |
Statyny do leczenia nadciśnienia śródgałkowego i jaskry
|
CN1988903A
(zh)
|
2004-07-20 |
2007-06-27 |
默克公司 |
用于治疗高眼压症的眼用组合物
|
AU2005295997A1
(en)
*
|
2004-10-13 |
2006-04-27 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
CA2583622A1
(fr)
*
|
2004-10-13 |
2006-04-27 |
Merck & Co., Inc. |
Compositions ophtalmiques de traitement de l'hypertension oculaire
|
ATE412400T1
(de)
*
|
2004-11-09 |
2008-11-15 |
Novagali Pharma Sa |
Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential
|
US7425572B2
(en)
*
|
2004-12-08 |
2008-09-16 |
Alcon, Inc. |
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
|
JP5060311B2
(ja)
*
|
2005-01-14 |
2012-10-31 |
アラーガン インコーポレイテッド |
高眼圧症状を処置するための置換シクロペンタンまたはシクロペンタノン
|
GB0501192D0
(en)
*
|
2005-01-20 |
2005-03-02 |
Resolution Chemicals Ltd |
Stable prostaglandin-containing compositions
|
US7851504B2
(en)
*
|
2005-03-16 |
2010-12-14 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
WO2010102078A1
(fr)
|
2009-03-04 |
2010-09-10 |
Allergan, Inc. |
Solution ophtalmique améliorée à base de bimatoprost
|
SI1864666T1
(sl)
|
2005-03-31 |
2012-10-30 |
Asahi Glass Co Ltd |
Zaščitno sredstvo za retinalno nevronsko celico, vsebujoče derivat prostaglandina F2 alfa kot učinkovino
|
US8252945B2
(en)
|
2005-04-13 |
2012-08-28 |
Ube Industries, Ltd. |
Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
|
US20060293378A1
(en)
*
|
2005-06-28 |
2006-12-28 |
Mcintire Gregory |
Method of lowering intraocular pressure
|
US20090270395A1
(en)
*
|
2005-08-03 |
2009-10-29 |
John Colucci |
EP4 Receptor Agonist, Compositions and Methods Thereof
|
TW200744567A
(en)
*
|
2005-09-23 |
2007-12-16 |
Alcon Inc |
Phenylethylamine analogs and their use for treating glaucoma
|
EP1810967B1
(fr)
|
2006-01-18 |
2014-07-30 |
Chirogate International Inc. |
Procédé et produits intérmediaires pour la fabrication de prostaglandines
|
WO2007091970A1
(fr)
*
|
2006-02-06 |
2007-08-16 |
Synphora Ab |
Nouvelles méthode et compositions pour traiter un acouphène
|
EP1994933B1
(fr)
*
|
2006-03-13 |
2017-04-26 |
R-Tech Ueno, Ltd. |
Composition aqueuse
|
WO2007108968A2
(fr)
*
|
2006-03-13 |
2007-09-27 |
Merck & Co., Inc. |
Compositions ophtalmiques pour le traitement de l'hypertension oculaire
|
WO2007111806A2
(fr)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Compositions et procedes pour la reduction des tissus adipeux de l'organisme
|
AU2007258527A1
(en)
*
|
2006-06-12 |
2007-12-21 |
Merck Sharp & Dohme Corp. |
Ophthalmic compositions for treating ocular hypertension
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
UY30883A1
(es)
|
2007-01-31 |
2008-05-31 |
Alcon Res |
Tapones punctales y metodos de liberacion de agentes terapeuticos
|
AU2008220104B2
(en)
|
2007-02-28 |
2012-09-27 |
Asahi Kasei Pharma Corporation |
Sulfonamide derivative
|
US20090018204A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Brinkenhoff Michael C |
Composition and method for enhancing hair growth
|
EP2291346A2
(fr)
*
|
2008-05-15 |
2011-03-09 |
Allergan, Inc. |
Cyclopentanes substitués à visée thérapeutique
|
US20080275118A1
(en)
*
|
2008-06-12 |
2008-11-06 |
Shaw Mari M |
Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
US8623918B2
(en)
|
2008-10-29 |
2014-01-07 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
US8722739B2
(en)
*
|
2008-10-29 |
2014-05-13 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
JP2012507552A
(ja)
|
2008-10-29 |
2012-03-29 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
プロスタグラジンのアミノ酸塩
|
US20100204335A1
(en)
*
|
2008-12-01 |
2010-08-12 |
Allergan, Inc. |
Kit and composition for eyelash growth
|
US20110293549A1
(en)
|
2009-02-03 |
2011-12-01 |
Athena Cosmetics, Inc. |
Composition, method and kit for enhancing hair
|
WO2010112615A1
(fr)
|
2009-04-03 |
2010-10-07 |
Dsm Ip Assets B.V. |
Dérivés de lysine fonctionnalisés avec des lipides
|
CA2760562C
(fr)
|
2009-05-01 |
2016-07-19 |
Aerie Pharmaceuticals, Inc. |
Inhibiteurs a mecanisme double pour le traitement de maladie
|
EP2478906A4
(fr)
|
2009-09-17 |
2013-02-20 |
Senju Pharma Co |
Gouttes ophtalmiques aqueuses qui contiennent du latanoprost, et procédé d'inhibition de l'adsorption du latanoprost sur une résine
|
US9149484B2
(en)
|
2009-11-09 |
2015-10-06 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
KR101769637B1
(ko)
|
2009-11-09 |
2017-08-18 |
알러간, 인코포레이티드 |
모발 성장을 촉진하기 위한 조성물 및 방법
|
EP2389939A1
(fr)
|
2010-05-28 |
2011-11-30 |
Novagali Pharma S.A. |
Utilisation de prostaglandines F2alpha et analogues pour la cicatrisation des lésions de la cornée et du conjonctif
|
US9522153B2
(en)
|
2009-12-22 |
2016-12-20 |
Allergan, Inc. |
Compositions and methods for lowering intraocular pressure
|
BR112013002584A2
(pt)
|
2010-08-02 |
2016-06-07 |
Pharma Patent Holding Inc |
composição, processo de kit para aperfeiçoamento de cabelo
|
EP3178465A1
(fr)
|
2010-12-06 |
2017-06-14 |
Follica, Inc. |
Procédé de traitement de calvitie et favorisant la pousse des cheveux
|
ES2687494T3
(es)
|
2011-01-19 |
2018-10-25 |
Topokine Therapeutics, Inc. |
Métodos y composiciones para reducir la grasa corporal
|
US8859616B2
(en)
|
2011-01-21 |
2014-10-14 |
Allergan, Inc. |
Compounds and methods for enhancing hair growth
|
TW201906614A
(zh)
|
2011-02-04 |
2019-02-16 |
日商興和股份有限公司 |
青光眼或高眼壓症之預防或治療用之點眼藥
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
HU231203B1
(hu)
*
|
2011-12-21 |
2021-10-28 |
CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. |
Új eljárás travoprost előállítására
|
US20150031898A1
(en)
*
|
2012-03-09 |
2015-01-29 |
Instytut Farmaceutyczny |
Process for preparation of prostaglandin f2 alpha analogues
|
SG11201600237YA
(en)
|
2012-11-21 |
2016-02-26 |
Topokine Therapeutics Inc |
Methods and compositions for locally increasing body fat
|
HU230744B1
(hu)
|
2012-11-30 |
2018-01-29 |
CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. |
Új eljárás travoprost előállítására
|
CA2905089C
(fr)
|
2013-03-15 |
2023-06-13 |
Aerie Pharmaceuticals, Inc. |
Compose d'isoquinoline pour traiter des maladies oculaires
|
NO2753788T3
(fr)
|
2013-05-10 |
2018-06-16 |
|
|
US9820993B2
(en)
|
2013-05-15 |
2017-11-21 |
Topokine Therapeutics, Inc. |
Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
|
EP3091985B1
(fr)
|
2014-01-10 |
2024-05-08 |
Manistee Therapeutics, Inc. |
Prostanglandines pour leur utilisation topique dans le traitement des migraines.
|
HU231214B1
(hu)
|
2014-03-13 |
2021-11-29 |
CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. |
Új eljárás nagytisztaságú prosztaglandinok előállítására
|
WO2015200425A1
(fr)
|
2014-06-27 |
2015-12-30 |
Topokine Therapeutics, Inc. |
Forme posologique à usage topique
|
AU2015332447B2
(en)
*
|
2014-10-15 |
2018-10-25 |
Alcon Inc. |
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension
|
US11285163B2
(en)
|
2014-10-20 |
2022-03-29 |
Sentiss Pharma Private Limited |
Ophthalmic solution
|
JP6686023B2
(ja)
|
2014-11-25 |
2020-04-22 |
エキシモア・リミテッドEximore Ltd. |
生物活性剤または生物活性剤類を送達する組成物および方法
|
WO2016155906A1
(fr)
|
2015-03-31 |
2016-10-06 |
Nicox S.A. |
Dérivés de fluprosténol donneurs d'oxyde nitrique
|
CA2999988C
(fr)
|
2015-09-27 |
2024-06-11 |
Follica, Inc. |
Dispositif de piqure et applicateur de medicament
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
DE102016110381A1
(de)
*
|
2016-06-06 |
2017-12-07 |
Edwin Kohl |
Kosmetische Zusammensetzung, insbesondere zur Förderung des Haarwuchses
|
US11478437B2
(en)
|
2016-07-05 |
2022-10-25 |
Jenivision Inc. |
Formulations for hair growth
|
CN109640966A
(zh)
|
2016-08-31 |
2019-04-16 |
爱瑞制药公司 |
眼用组合物
|
EP3609871A4
(fr)
|
2017-03-31 |
2021-01-06 |
Aerie Pharmaceuticals, Inc. |
Composés d'amide aryl cyclopropyl-amino-isoquinolinyl
|
US11427563B2
(en)
|
2018-09-14 |
2022-08-30 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|